Stockreport

Edesa Biotech Reports Fiscal Year 2025 Results

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeuti [Read more]